Sorrento Therapeutics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Sorrento Therapeutics, Inc. (SRNEQ) is 0.29

According to Sorrento Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.29. This represents a change of -48.46% compared to the average of 0.57 of the last 4 quarters.

Sorrento Therapeutics, Inc. (SRNEQ) Historical Current Ratio (quarterly & annually)

How has SRNEQ Current Ratio performed in the past?

The mean historical Current Ratio of Sorrento Therapeutics, Inc. over the last ten years is 2.57. The current 0.29 Current Ratio has changed 1.04% with respect to the historical average. Over the past ten years (40 quarters), SRNEQ's Current Ratio was at its highest in in the December 2014 quarter at 7.73. The Current Ratio was at its lowest in in the December 2022 quarter at 0.29.

Sorrento Therapeutics, Inc. (SRNEQ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sorrento Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sorrento Therapeutics, Inc. (SRNEQ) Average Current Ratio

How has SRNEQ Current Ratio performed in the past?

The current Current Ratio of Sorrento Therapeutics, Inc. (SRNEQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sorrento Therapeutics, Inc. (SRNEQ) Current Ratio vs. Peers

How is SRNEQ’s Current Ratio compared to its peers?

Sorrento Therapeutics, Inc.’s Current Ratio is less than American Hemp Ventures, Inc. (0), less than Malachite Innovations, Inc. (0.57), less than Noxopharm Limited (0.81), less than Avecho Biotechnology Limited (9.95), greater than Rapid Dose Therapeutics Corp. (0.08), less than OKYO Pharma Limited (0.58), greater than Poxel S.A. (0.26), less than Ceapro Inc. (8.54), less than Organicell Regenerative Medicine, Inc. (1.05), less than Eiger BioPharmaceuticals, Inc. (0.71),

Build a custom stock screener for Sorrento Therapeutics, Inc. (SRNEQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sorrento Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sorrento Therapeutics, Inc. (SRNEQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sorrento Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.